This was also confirmed by the fact that the XBP1+/RIDD− population was enriched in mesenchymal tumors whereas XBP1−/RIDD+ comprised more pro‐neural and neural tumors (Appendix Fig S7C). The gene discussed is XBP1; the disease is nervous system cancer.